# US 7,910,294 B2 · Ligand detection method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 7,910,294 B2
- Document ID: US7910294B2
- Status: Granted
- Kind: B2
- Application number: 10/433,548
- Filed: 2001-12-05
- Published: 2004-04-22
- Granted: 2011-03-22
- Earliest claimed: 2000-12-05
- Assignees: Norchip A/S
- Inventors: Frank Karlsen
- Web page: https://patentgrep.com/patent/US7910294B2

## CPC

- G01N 33/566: using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds}
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

There is disclosed a sensitive method for specific detection of ligands comprising the steps of (a) contacting the sample with reagents capable of forming a reagent complex, which reagent complex comprises a receptor capable of specifically binding to said ligand and a nucleic acid molecule; and (b) detecting any complexes formed by binding of the receptor part of said reagent complex to ligand present in the sample by specifically detecting the presence of the nucleic acid molecule by amplifying a region of the nucleic acid and simultaneously detecting products of the amplification reaction in real-time.

## Claims

### Claim 1

A method for detecting a ligand in a sample, which method comprises steps of:
(a) contacting the sample with reagents capable of forming a reagent complex, which reagent complex comprises a receptor capable of specifically binding to said ligand, said receptor is linked to a nucleic acid molecule; and
(b) detecting any complexes formed by binding of the receptor part of said reagent complex to ligand present in the sample by specifically detecting the presence of the nucleic acid molecule by amplifying a region of the nucleic acid using a nucleic acid sequence based amplification reaction (NASBA) and simultaneously detecting products of the amplification reaction in real-time.

### Claim 2 (depends on 1)

A method according to claim 1 wherein step (a) comprises sequential or simultaneous steps of:
(i) contacting the sample with receptors capable of binding to said ligand, said receptors being conjugated with a first component of a biological binding pair; and
(ii) contacting the sample with nucleic acid molecules conjugated with a second component of a biological binding pair.

### Claim 3 (depends on 1)

A method according to claim 1 wherein step (a) comprises sequential or simultaneous steps of:
(i) contacting the sample with receptors capable of binding to said ligand; and
(ii) contacting the sample with secondary receptors capable of binding to the receptors of part (i), said secondary receptors being linked to nucleic acid molecules.

### Claim 4 (depends on 1)

A method according to claim 1 wherein step (a) comprises sequential or simultaneous steps of:
(i) contacting the sample with receptors capable of binding to said ligand;
(ii) contacting the sample with secondary receptors capable of binding to the receptors of part (i), said secondary receptors being conjugated with a first member of a biological binding pair; and
(iii) contacting the sample with single stranded nucleic acid molecules conjugated with a second member of a biological binding pair.

### Claim 5 (depends on 1)

A method according to claim 1 wherein step (a) comprises sequential or simultaneous steps of:
(i) contacting the sample with receptors capable of binding to said ligand;
(ii) contacting the sample with secondary receptors capable of binding to the receptors of part (i), said secondary receptors being conjugated with a first member of a biological binding pair;
(iii) contacting the sample with nucleic acid molecules conjugated with a first member of a biological binding pair at one end and a second member of a biological binding pair at the other end of the nucleic acid strand; and
(iv) contacting the sample with nucleic acid molecules conjugated with a second member of the biological binding pair only.

### Claim 6 (depends on 2)

A method according to claim 2, wherein the first and second components of the biological binding pair are streptavidin or avidin and biotin, or vice versa.

### Claim 7 (depends on 3)

A method according to claim 3 wherein said secondary receptor is linked to said nucleic acid molecules by a direct chemical bond.

### Claim 8 (depends on 1)

A method according to claim 1 wherein step (a) comprises the addition of a reagent complex which is a conjugate comprising receptors capable of binding to the ligand, nucleic acid molecules and a carrier macromolecule.

### Claim 9 (depends on 8)

A method according to claim 8 wherein the carrier macromolecule is a dextran.

### Claim 10 (depends on 1)

A method according to claim 1 wherein the receptors capable of binding to said ligand are antibodies or antibody fragments.

### Claim 11 (depends on 1)

A method according to claim 1 wherein the nucleic acid is partially or completely single-stranded.

### Claim 12 (depends on 11)

A method according to claim 11 wherein the nucleic acid is a single-stranded DNA or RNA.

### Claim 13 (depends on 3)

A method according to claim 3, wherein the first and second components of the biological binding pair are streptavidin or avidin and biotin, or vice versa.

### Claim 14 (depends on 4)

A method according to claim 4, wherein the first and second components of the biological binding pair are streptavidin or avidin and biotin, or vice versa.

### Claim 15 (depends on 5)

A method according to claim 5, wherein the first and second components of the biological binding pair are streptavidin or avidin and biotin, or vice versa.
